# Biannual Screening for HCC Offered to Patients With Cirrhosis. Introducing Surveillance for Hepatocellular Carcinoma (HCC) in the Central Denmark Region Using Ultrasound and Alpha-Fetoprotein to Reduce HCC-Related Mortality in Patients With Compensated Non-Viral Cirrhosis

> **NCT07469319** · NA · RECRUITING · sponsor: **University of Aarhus** · enrollment: 617 (estimated)

## Conditions studied

- Hepatocellular Carcinoma (HCC)
- Cirrhosis

## Interventions

- **DIAGNOSTIC_TEST:** Ultrasound of the liver and blood sample for alpha-fetoprotein

## Key facts

- **NCT ID:** NCT07469319
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-06-30
- **Target enrollment:** 617 (ESTIMATED)
- **Last updated:** 2026-03-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07469319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07469319, "Biannual Screening for HCC Offered to Patients With Cirrhosis. Introducing Surveillance for Hepatocellular Carcinoma (HCC) in the Central Denmark Region Using Ultrasound and Alpha-Fetoprotein to Reduce HCC-Related Mortality in Patients With Compensated Non-Viral Cirrhosis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07469319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*